Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Rite Aid Corporation (RAD), Micron Technology, Inc. (MU), Genworth Financial Inc (GNW): Zeroing In on Big Value Line Winners

Page 1 of 2

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you’d like to add some stocks that have earned Value Line “timeliness” ratings of 1 to your portfolio but don’t have the time or expertise to hand-pick a few, the First Trust Value Line 100 ETF could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.

The basics

ETFs often sport lower expense ratios than their mutual fund cousins. The First Trust ETF’s expense ratio — its annual fee — is 0.70%, a bit higher than many ETFs but still lower than the typical stock mutual fund. The fund is fairly small, too, so if you’re thinking of buying, beware of possibly large spreads between its bid and ask prices. Consider using a limit order if you want to buy in.

This ETF has performed reasonably, but it’s also very young, with just a few years on the books. It underperformed the S&P 500 in 2008 and 2010, though it beat it substantially in 2007 and 2009. As with most investments, of course, we can’t expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.

Why Value Line?

Many successful investors have found solid investment ideas among those stocks with top ratings for timeliness by the folks at Value Line. While some shake their head at Value Line’s history, others still consult its offerings.

Rite Aid Corporation (NYSE:RAD)

More than a handful of companies that have been rated highly by Value Line had very strong performances over the past year. Rite Aid Corporation (NYSE:RAD) surged 178% over the past year, as its successful turnaround has progressed, but it’s losing prescription market share to Walgreen and carries more debt than competitors, which it has been addressing in part by closing some stores. Still, still, it’s posting growth and net gains instead of losses lately, so there is reason to be hopeful. It’s also poised to profit from Obamacare, which should deliver more insured Americans demanding more medications. Some think it might end up acquired, but others think that’s far from necessary.

Micron Technology, Inc. (NASDAQ:MU) soared 146%, successfully adapting to a changing market. The memory giant’s acquisition of Japanese manufacturer Elpida has boosted its capacity, its pricing power, and its relationship with AppleMicron Technology, Inc. (NASDAQ:MU) beat expectations for both revenue and earnings in its last quarter, and is downsizing its workforce by about 5% — but its earnings have recently been in the red, and its margins shrinking. It faces able competition, too, but with its forward P/E is near 11, Micron Technology, Inc. (NASDAQ:MU) seems appealingly priced. A recent boon  for Micron Technology, Inc. (NASDAQ:MU) is a fire at a competitor’s plant.

Genworth Financial Inc (NYSE:GNW) jumped 109%, in part on second-quarter results that featured earnings up 86% and a strong performance by its mortgage insurance business. Revenue dropped 1.3%, though, and lagged expectations. Genworth Financial Inc (NYSE:GNW) has been cutting costs via downsizing, and is poised to benefit from a rebound in housing, as it insures mortgages. Some worry, though, that tightening lending standards may result in less need for its insurance. Bulls like its selling off its wealth management business — and that it may also exit the long-term care insurance business, too, if it doesn’t win rate increases. (Genworth Financial Inc (NYSE:GNW) and John Hancock are the two big players left in the business.) Genworth stock looks appealing with its forward P/E ratio under 9, well below its five-year average.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!